Ras oncogenes: split personalities

Cited by (1,000)

Items 601–700 of 1,000

1. KRAS Codon 12 Mutation is Associated with More Aggressive Invasiveness in Synchronous Metastatic Colorectal Cancer (mCRC): Retrospective Research
   Kang He, Yajing Wang, Yuejiao Zhong, Xiaohua Pan, Lixiang Si, Jianwei Lu · 2020 · OncoTargets and Therapy
2. Small-Molecule RAS Inhibitors as Anticancer Agents: Discovery, Development, and Mechanistic Studies
   Shaila A. Shetu, Debasish Bandyopadhyay · 2022 · International Journal of Molecular Sciences
3. Targeting oncogenic KRAS in non-small cell lung cancer with EGFR aptamer-conjugated multifunctional RNA nanoparticles
   Linlin Yang, Zhefeng Li, Daniel W. Binzel, Peixuan Guo, Terence Marques Williams · 2023 · Molecular Therapy — Nucleic Acids
4. Computational allosteric ligand binding site identification on Ras proteins
   Michael J. McCarthy, Priyanka Prakash, Alemayehu Abebe Gorfe · 2015 · Acta Biochimica et Biophysica Sinica
5. κB-Ras Is a Nuclear-Cytoplasmic Small GTPase That Inhibits NF-κB Activation through the Suppression of Transcriptional Activation of p65/RelA
   Kenji Tago, Megumi Funakoshi‐Tago, Masaki Sakinawa, Norikazu Mizuno, Hiroshi Itoh · 2010 · Journal of Biological Chemistry
6. RASAL1 influences the proliferation and invasion of gastric cancer cells by regulating the RAS/ERK signaling pathway
   Hong Chen, Zhengyuan Cheng, Ying Pan, Zhi Wang, Yang Liu, Jin-Qi Zhang · 2014 · Human Cell
7. Transforming growth factor-beta signaling network regulates plasticity and lineage commitment of lung cancer cells
   Irene Ischenko, J Liu, Oleksi Petrenko, Michael J. Hayman · 2014 · Cell Death and Differentiation
8. Novel Candidate Key Drivers in the Integrative Network of Genes, MicroRNAs, Methylations, and Copy Number Variations in Squamous Cell Lung Carcinoma
   Tao Huang, Yang Jing, Yu‐Dong Cai · 2015 · BioMed Research International
9. K-Ras mutation-mediated IGF-1-induced feedback ERK activation contributes to the rapalog resistance in pancreatic ductal adenocarcinomas
   Wei Feng, Yan Liu, Anita C. Bellail, Jeffrey J. Olson, Shi Yong Sun, Guoyue Lu, Lijuan Ding, Changji Yuan, Guangyi Wang, Chunhai Hao · 2012 · Cancer Letters
10. Noonan syndrome‐like disorder with loose anagen hair: A second case with neuroblastoma
    Livia Garavelli, Viviana Cordeddu, Stefania Errico, Patrizia Bertolini, Maria Elisabeth Street, Simonetta Rosato, Marzia Pollazzon, Anita Wischmeijer, Ivan P. Ivanovski, Paola Daniele et al. · 2015 · American Journal of Medical Genetics Part A
11. Mixed-Probe Simulation and Probe-Derived Surface Topography Map Analysis for Ligand Binding Site Identification
    Abdallah Sayyed–Ahmad, Alemayehu Abebe Gorfe · 2017 · Journal of Chemical Theory and Computation
12. Anti-helminthic niclosamide inhibits Ras-driven oncogenic transformation via activation of GSK-3
    Sung Yong Ahn, Ji Hye Yang, Nam Hee Kim, Kyungro Lee, Yong Hoon Cha, Jun Seop Yun, Hee Eun Kang, Yoonmi Lee, Jiwon Choi, Hyun Sil Kim et al. · 2017 · Oncotarget
13. K-ras Mutations as the Earliest Driving Force in a Subset of Colorectal Carcinomas
    Nikolaos Margetis, Myrsini Kouloukoussa, KYRIAKI PAVLOU, Spyridon Vrakas, Theodoros D. Mariolis-Sapsakos · 2017 · In Vivo
14. Targeting autophagy with small molecules for cancer therapy
    Sree Karani Kondapuram, Sailu Sarvagalla, Mohane Selvaraj Coumar · 2019 · Journal of Cancer Metastasis and Treatment
15. New druggable targets in the Ras pathway?
    David Matallanas, Piero Crespo · 2010 · PubMed
16. AMPK activation overcomes anti-EGFR antibody resistance induced by KRAS mutation in colorectal cancer
    Ye, Hua, Liu, Yi, Wu, Kefeng, Luo, Hui, Cui, Liao · 2020 · Cell Communication and Signaling
17. Ras palmitoylation is necessary for N-Ras activation and signal propagation in growth factor signalling
    Shu-Ping Song, Anne Hennig, Katja Schubert, Robby Markwart, Philipp Schmidt, Ian A. Prior, Frank-Dietmar Böhmer, Ignacio Rubio · 2013 · Biochemical Journal
18. Signal transduction pathway mutations in gastrointestinal (GI) cancers: a systematic review and meta-analysis
    Alireza Tabibzadeh, Fahimeh Safarnezhad Tameshkel, Yousef Moradi, Saber Soltani, Maziar Moradi‐Lakeh, Gholam Hossein Ashrafi, Nima Motamed, Farhad Zamani, Seyed Abbas Motevalian, Mahshid Panahi et al. · 2020 · Scientific Reports
19. A CRISPR-Cas9 repressor for epigenetic silencing of KRAS
    Jingwen Liu, Meiyan Sun, Kwang Bog Cho, Xiang Gao, Bin Guo · 2020 · Pharmacological Research
20. GINS1 Induced Sorafenib Resistance by Promoting Cancer Stem Properties in Human Hepatocellular Cancer Cells
    Sheng Li, Lina Wu, Hong Zhang, Xijuan Liu, Zilei Wang, Bin Dong, Guang Cao · 2021 · Frontiers in Cell and Developmental Biology
21. Cyclin‐dependent kinases as therapeutic targets in melanoma
    David Michael Miller, Keith T. Flaherty · 2014 · Pigment Cell & Melanoma Research
22. Ras and Rheb Signaling in Survival and Cell Death
    Anja Ehrkamp, Christian Herrmann, Raphael Stoll, Rolf Heumann · 2013 · Cancers
23. Combined treatment with bexarotene and rosuvastatin reduces angiotensin‐ II ‐induced abdominal aortic aneurysm in apo E −/− mice and angiogenesis
    P. Escudero, A Navarro, Carlos Ferrando, Elena Furió, Herminia González Navarro, Marina Juez, María‐Jesús Sanz, Laura Piqueras · 2015 · British Journal of Pharmacology
24. LvRas and LvRap are both important for WSSV replication in Litopenaeus vannamei
    Yi-Ting Tseng, Ramya Kumar, Han‐Ching Wang · 2019 · Fish & Shellfish Immunology
25. Insights into the classification of small GTPases
    Dominik Heider, Hauke, Pyka, Keßler · 2010 · Advances and Applications in Bioinformatics and Chemistry
26. Decreased bone mineral density in Costello syndrome
    Chiara Leoni, David A. Stevenson, Lucilla Martini, Roberto De Sanctis, Giovanna Mascolo, Francesca Pantaleoni, Sara De Santis, Ilaria La Torraca, Silvia Persichilli, Paolo Caradonna et al. · 2013 · Molecular Genetics and Metabolism
27. In Vivo Regulation of TGF-β by R-Ras2 Revealed through Loss of the RasGAP Protein NF1
    Deanna M. Patmore, Sara Welch, Patricia C. Fulkerson, Jianqiang Wu, Kwangmin Choi, David W. Eaves, Jennifer J. Kordich, Margaret H. Collins, Timothy P. Cripe, Nancy Ratner · 2012 · Cancer Research
28. Current status of the development of Ras inhibitors
    Fumi Shima, Shigeyuki Matsumoto, Yoko Yoshikawa, Takashi Kawamura, Masayuki Isa, Tohru Kataoka · 2015 · The Journal of Biochemistry
29. MicroRNA-630 suppresses epithelial-to-mesenchymal transition by regulating FoxM1 in gastric cancer cells
    Jing Feng, Xiaojuan Wang, Weihua Zhu, Si Chen, Changwei Feng · 2017 · Biochemistry (Moscow)
30. Computational Insights into the Interactions between Calmodulin and the c/nSH2 Domains of p85α Regulatory Subunit of PI3Kα: Implication for PI3Kα Activation by Calmodulin
    Duan Ni, Dingyu Liu, Jian Zhang, Shaoyong Lu · 2018 · International Journal of Molecular Sciences
31. TYMS/KRAS/BRAF molecular profiling predicts survival following adjuvant chemotherapy in colorectal cancer
    Anastasios Ntavatzikos, Aris Spathis, Paul Patapis, Nikolaos Machairas, Georgia Vourli, George Peros, Iordanis N. Papadopoulos, Ioannis G Panayiotides, Anna A. Koumarianou · 2019 · World Journal of Gastrointestinal Oncology
32. Role of Prohibitins in Aging and Therapeutic Potential Against Age-Related Diseases
    Misa Belser, David W. Walker · 2021 · Frontiers in Genetics
33. Probing mutation-induced conformational transformation of the GTP/M-RAS complex through Gaussian accelerated molecular dynamics simulations
    Huayin Bao, Wei Wang, Haibo Sun, Jianzhong Chen · 2023 · Journal of Enzyme Inhibition and Medicinal Chemistry
34. Translating biology into clinic: the case of glioblastoma
    Maria Maddalena Lino, Adrian Merlo · 2009 · Current Opinion in Cell Biology
35. Cancer therapy targeted at cellular signal transduction mechanisms: Strategies, clinical results, and unresolved issues
    Thoralf Christoffersen, Tormod Kyrre Guren, Karen‐Lise Garm Spindler, Olav Dahl, Per Eystein Lønning, Bjørn Tore Gjertsen · 2009 · European Journal of Pharmacology
36. H-Ras and K-Ras Oncoproteins Induce Different Tumor Spectra When Driven by the Same Regulatory Sequences
    Matthias Drosten, Lucía Simón-Carrasco, Isabel Hernández-Porras, Carmen G. Lechuga, María Teresa Blasco, Harrys K.C. Jacob, Salvatore Fabbiano, Nicoletta Potenza, Xosé R. Bustelo, Carmen E. Guerra et al. · 2016 · Cancer Research
37. A computationally engineered RAS rheostat reveals RAS–ERK signaling dynamics
    John C. Rose, Po‐Ssu Huang, Nathan D. Camp, Jordan Ye, Andrew M. Leidal, Inna Goreshnik, Bridget M. Trevillian, Miles Sasha Dickinson, Daniel Cunningham‐Bryant, Jayanta Debnath et al. · 2016 · Nature Chemical Biology
38. Association of MTH1 expression with the tumor malignant potential and poor prognosis in patients with resected lung cancer
    Takatoshi Fujishita, Tatsuro Okamoto, Takaki Akamine, Shinkichi Takamori, Kazuki Takada, Masakazu Katsura, Gouji Toyokawa, Fumihiro Shoji, Mototsugu Shimokawa, Yoshinao Oda et al. · 2017 · Lung Cancer
39. MISTIC2: comprehensive server to study coevolution in protein families
    Eloy A Colell, Javier Iserte, Franco L. Simonetti, Cristina Marino‐Buslje · 2018 · Nucleic Acids Research
40. Molecular characterization and biomarker identification in colorectal cancer: Toward realization of the precision medicine dream
    Gaurav Goel · 2018 · Cancer Management and Research
41. Proof of concept for poor inhibitor binding and efficient formation of covalent adducts of KRAS G12C and ARS compounds
    Maria G. Khrenova, Anna M. Kulakova, Alexander V. Nemukhin · 2020 · Organic & Biomolecular Chemistry
42. Dynamically encoded reactivity of Ras enzymes: opening new frontiers for drug discovery
    Gyula Pálfy, Dóra K. Menyhárd, András Perczel · 2020 · Cancer and Metastasis Reviews
43. Gene-expression profiles in lung adenocarcinomas related to chronic wood smoke or tobacco exposure
    Alette Ortega-Gómez, Claudia Rangel‐Escareño, Camilo Molina-Romero, Eleazar Omar Macedo-Pérez, Alejandro Avilés‐Salas, Alejandra Lara-García, Gerardo J. Alanis-Funes, Rubén Rodríguez‐Bautista, Alfredo Hidalgo‐Miranda, Oscar G. Arrieta · 2016 · Respiratory Research
44. Advances in the treatment of KRASG12C mutant non–small cell lung cancer
    Khvaramze Shaverdashvili, Timothy Francis Burns · 2025 · Cancer
45. Inhibiting the RAS–PI3K Pathway in Cancer Therapy
    Clare Sheridan, Julian Downward · 2013 · The Enzymes
46. Glycyrrhetinic acid binds to the conserved P-loop region and interferes with the interaction of RAS-effector proteins
    Yuan Zhang, Zhihua Wang, Xiaoyao Ma, Shengnan Yang, Xueyan Hu, Jin Tao, Yuanyuan Hou, Gang Bai · 2018 · Acta Pharmaceutica Sinica B
47. Regulation of HMGA2 and KRAS genes in epithelial ovarian cancer by miRNA hsa-let-7d-3p
    Tuba Günel, Berkcan Doğan, Ece Gümüşoğlu-Acar, Mohammad Kazem Hosseini, Samet Topuz, Kılıç Aydinli · 2019 · Journal of Cancer Research and Therapeutics
48. Targeting RAS-RAF pathway significantly improves antitumor activity of Rigosertib-derived platinum(IV) complexes and overcomes cisplatin resistance
    Zhikun Liu, Meng Wang, Heng‐Shan Wang, Lei Fang, Shaohua Gou · 2020 · European Journal of Medicinal Chemistry
49. AGO2 promotes tumor progression in KRAS-driven mouse models of non–small cell lung cancer
    Jean Ching-Yi Tien, Seema Chugh, Andrew E. Goodrum, Yunhui Cheng, Rahul Mannan, Yuping Zhang, Lisha Wang, Vijaya L. Dommeti, Xiaoming Wang, Alice Xu et al. · 2021 · Proceedings of the National Academy of Sciences
50. Realgar‑induced KRAS mutation lung cancer cell death via KRAS/Raf/MAPK mediates ferroptosis
    Xiaofeng Liu, Yang Hai, Jinqu Dong, Lan Xu, Wenqian Hou, Jing Su, Weiyu Ren, Dongling Liu · 2022 · International Journal of Oncology
51. Identification of a ternary protein-complex as a therapeutic target for K-Ras-dependent colon cancer
    Xiao-Mei Qi, Congying Xie, Songwang Hou, Gang Li, Ning B. Yin, Lei Dong, Adrienne Lepp, Marla A. Chesnik, Shama P. Mirza, Anikó Szabó et al. · 2014 · Oncotarget
52. Interferon-β Signaling Contributes to Ras Transformation
    Yu‐Chen Tsai, Sidney Pestka, Lu‐Hai Wang, Loren Warren Runnels, Shan Wan, Yi Lisa Lyu, Leroy F. Liu · 2011 · PLoS ONE
53. Dual Inhibition of GLUT1 and the ATR/CHK1 Kinase Axis Displays Synergistic Cytotoxicity in KRAS -Mutant Cancer Cells
    Johanna Erber, Joachim David Steiner, Jörg Isensee, Leonard A. Lobbes, André Toschka, Filippo Beleggia, Anna Schmitt, Rainer W. J. Kaiser, Florian Siedek, Thorsten Persigehl et al. · 2019 · Cancer Research
54. Benzo[a]pyrene at human blood equivalent level induces human lung epithelial cell invasion and migration via aryl hydrocarbon receptor signaling
    Han Gao, Guozhu Ye, Yi Lin, Yulang Chi, Sijun Dong · 2020 · Journal of Applied Toxicology
55. Ras, Rac1, and phosphatidylinositol-3-kinase (PI3K) signaling in nitric oxide induced endothelial cell migration
    Roberta Eller Borges, Wagner Luiz Batista, Paulo Eduardo da Costa, Rita Tokikawa, Marli F. Curcio, Scheilla Teixeira Strumillo, Adriano Sartori, Miriam Santos de Moraes, Graciele Almeida de Oliveira, Murched Omar Taha et al. · 2015 · Nitric Oxide
56. Targeting signaling pathways with andrographolide in cancer therapy (Review)
    Nur Shahirah Shaharudin, Gurmeet Kaur Surindar Singh, Teh Kek, Sadia Sultan · 2024 · Molecular and Clinical Oncology
57. Monitoring the Waiting Time Sequence of Single Ras GTPase Activation Events Using Liposome Functionalized Zero-Mode Waveguides
    Sune M. Christensen, Meredith Gahn Triplet, Christopher Rhodes, Jeffrey S. Iwig, Hsiung‐Lin Tu, Dimitrios G. Stamou, Jay T. Groves · 2016 · Nano Letters
58. A Survey of Computational Treatments of Biomolecules by Robotics-Inspired Methods Modeling Equilibrium Structure and Dynamic
    Amarda Shehu, Erion Plaku · 2016 · Journal of Artificial Intelligence Research
59. KRAS G12C fragment screening renders new binding pockets
    Magali Mathieu, Valérie Steier, Florence Fassy, Cécile Delorme, David Papin, Bruno Genêt, Francis Duffieux, Thomas Bertrand, Laure Delarbre, Hélène Le-Borgne et al. · 2021 · Small GTPases
60. Inhibition of Ras Signaling by Blocking Ras–Effector Interactions with Cyclic Peptides
    Punit Upadhyaya, Ziqing Qian, Nicholas G. Selner, Sarah R. Clippinger, Zhengrong Wu, Roger Briesewitz, Dehua Pei · 2015 · Angewandte Chemie
61. The down-regulation of GNAO1 and its promoting role in hepatocellular carcinoma
    Xiaoyu Pei, Jun Zhang, Lijun Wu, Bin Lü, Xiaojiao Zhang, Dongqin Yang, Jie Liu · 2013 · Bioscience Reports
62. Identification and Expression Analysis of Ras Gene in Silkworm, Bombyx mori
    Takehiko Ogura, Anjiang Tan, Takuya Tsubota, Takayo Nakakura, Takahiro Shiotsuki · 2009 · PLoS ONE
63. Activated Ras alters lens and corneal development through induction of distinct downstream targets
    Daniel J Burgess, Yan Zhang, Ed Siefker, R. A. Vaca, Murali R. Kuracha, Lixing W. Reneker, Paul A. Overbeek, Venkatesh Govindarajan · 2010 · BMC Developmental Biology
64. Reduced expression of RAS protein activator like‐1 in gastric cancer
    Motoko Seto, Miki Ohta, Tsuneo Ikenoue, Takafumi Sugimoto, Yoshinari Asaoka, Motohisa Tada, Dai Mohri, Yotaro Kudo, Hideaki Ijichi, Keisuke Tateishi et al. · 2010 · International Journal of Cancer
65. Significance of Ras Signaling in Cancer and Strategies for its Control
    Arun Bahadur Gurung, Atanu Bhattacharjee, Researcher · 2015 · touchREVIEWS in Oncology & Haematology
66. KIF2A Overexpression and Its Association with Clinicopathologic Characteristics and Poor Prognoses in Patients with Gastric Cancer
    Shu Zhang, Fang Huang, Yan Wang, Qinjie Song, Xiaobing Yang, Han Jiang Wu · 2016 · Disease Markers
67. Solubility survey of fragments of the neurofibromatosis type 1 protein neurofibromin
    Fabien Bonneau, Esther D. Lenherr, Vladimir Peña, Darren J. Hart, Klaus Scheffzek · 2008 · Protein Expression and Purification
68. A novel HRAS substitution (c.266C>G; p.S89C) resulting in decreased downstream signaling suggests a new dimension of RAS pathway dysregulation in human development
    Karen Webster Gripp, Eugenia Bifeld, Deborah L. Stabley, Elizabeth Hopkins, Stefanie Meien, Kathy M. B. Vinette, Katia Sol‐Church, Georg Rosenberger · 2012 · American Journal of Medical Genetics Part A
69. Mutations in the KRAS gene in ovarian tumors.
    Bożena Dobrzycka, Slawomir Jerzy Terlikowski, Oksana Kowalczuk, Wiesława Niklińska, L Chyczewski, M Kulikowski · 2009 · Folia Histochemica et Cytobiologica
70. RAS-Mutant Follicular Thyroid Tumors: A Continuous Challenge for Pathologists
    Juan Carlos Hernandez-Prera, Bruce M. Wenig · 2024 · Endocrine Pathology
71. Panitumumab in Metastatic Colorectal Cancer: The Importance of Tumour RAS Status
    Marc Peeters, Meinolf Karthaus, Fernando Rivera, Jan-Henrik Terwey, Jean‐Yves Douillard · 2015 · Drugs
72. Computing energy landscape maps and structural excursions of proteins
    Emmanuel Sapin, Daniel B. Carr, Kenneth Alan De Jong, Amarda Shehu · 2016 · BMC Genomics
73. Prognostic Characteristics and Immunotherapy Response of Patients With Nonsquamous NSCLC With Kras Mutation in East Asian Populations: A Single-Center Cohort Study in Taiwan
    Shang‐Gin Wu, Wei‐Yu Liao, Kang‐Yi Su, Sung‐Liang Yu, Yen-Lin Huang, Chong‐Jen Yu, James Chih‐Hsin Yang, Jin‐Yuan Shih · 2020 · JTO Clinical and Research Reports
74. Determinants of Membrane Orientation Dynamics in Lipid-Modified Small GTPases
    Priyanka Prakash, Alemayehu Abebe Gorfe · 2021 · JACS Au
75. Identification of the nucleotide-free state as a therapeutic vulnerability for inhibition of selected oncogenic RAS mutants
    Imran Khan, Akiko Koide, Mariyam Zuberi, Gayatri Ketavarapu, Eric Denbaum, Kai Wen Teng, Joshua Matthew Rhett, Russell Spencer-Smith, G. Aaron Hobbs, Ernest Ramsay Camp et al. · 2022 · Cell Reports
76. Aberrant MAPK Signaling Offers Therapeutic Potential for Treatment of Ovarian Carcinoma
    Eva Colic, Preya U. Patel, Oliver A. Kent · 2022 · OncoTargets and Therapy
77. Statistical mechanics of protein allostery: Roles of backbone and side-chain structural fluctuations
    Kazuhito Itoh, Masaki Sasai · 2011 · The Journal of Chemical Physics
78. Downregulated adaptor protein p66Shc mitigates autophagy process by low nutrient and enhances apoptotic resistance in human lung adenocarcinoma A549 cells
    Zhichao Zheng, Jie Yang, Dan Zhao, Dan Gao, Xiaojie Yan, Zhi Yao, Zhe Liu, Zhenyi Ma · 2013 · FEBS Journal
79. A New Dimension to Ras Function: A Novel Role for Nucleotide-Free Ras in Class II Phosphatidylinositol 3-Kinase Beta (PI3KC2β) Regulation
    Katy Ann Wong, Angela Russo, Xuerong Wang, Yun-Ju Chen, Arnon Lavie, John P. O’Bryan · 2012 · PLoS ONE
80. Tumour cell responses to MEK1/2 inhibitors: acquired resistance and pathway remodelling
    Annette S. Little, Kathryn Balmanno, Matthew J. Sale, Paul D. Smith, Simon J. Cook · 2012 · Biochemical Society Transactions
81. Current Trends in Cancer Therapy
    Navjot Sekhon, Rekha Anjali Kumbla, Monica M Mita · 2016 · Elsevier eBooks
82. Therapeutic predictors of neoadjuvant endocrine therapy response in estrogen receptor-positive breast cancer with reference to optimal gene expression profiling
    Lisa Goto‐Yamaguchi, Mutsuko Yamamoto‐Ibusuki, Yutaka Yamamoto, Yoshitaka Fujiki, Mai Tomiguchi, Aiko Sueta, Takashi Takeshita, Hirotaka Iwase · 2018 · Breast Cancer Research and Treatment
83. Ras-Mediated Activation of NF-κB and DNA Damage Response in Carcinogenesis
    Anas Ahmad, Haseeb Ahsan · 2020 · Cancer Investigation
84. RETRACTED: Arginine methylation of SHANK2 by PRMT7 promotes human breast cancer metastasis through activating endosomal FAK signalling
    Yingqi Liu, Lingling Li, Xiaoqing Liu, Yibo Wang, Lu Peng, Jiayuan Liu, Lingling Li, Lian Zhang, Guannan Wang, Hongyuan Li et al. · 2020 · eLife · Retracted
85. Rho Family of Ras-Like GTPases in Early-Branching Animals
    Silvestar Beljan, Maja Herak Bosnar, Helena Ćetković · 2020 · Cells
86. A comprehensive analysis of somatic alterations in Chinese ovarian cancer patients
    Yingli Zhang, Xiaoliang Shi, Jiejie Zhang, Xi Chen, Peng Zhang, Angen Liu, Tao Zhu · 2021 · Scientific Reports
87. A comprehensive analysis of RAS-effector interactions reveals interaction hotspots and new binding partners
    Soheila Rezaei Adariani, Neda S. Kazemein Jasemi, Farhad Bazgir, Christoph Wittich, Ehsan Amin, Claus A. M. Seidel, Radovan Dvorský, Mohammad Reza Ahmadian · 2021 · Journal of Biological Chemistry
88. Chapter 5 Rab Proteins and Their Interaction Partners
    Angelika Barnekow, Anika Thyrock, Daniel Kessler · 2009 · International review of cytology
89. Ras and Nox: Linked signaling networks?
    Ru Feng Wu, Lance S. Terada · 2009 · Free Radical Biology and Medicine
90. Identification of Structurally Novel KRAS G12C Inhibitors through Covalent DNA-Encoded Library Screening
    David S. Huang, Francesco Manoni, Zhen Sun, Rongfeng Liu, Jennifer R. Allen, Abhisek Banerjee, Victor J. Cee, Josephine Eshon, Michael J. Frohn, Matthew R. Kaller et al. · 2025 · Journal of Medicinal Chemistry
91. Disarming mutant p53 oncogenic function
    Javier E. Girardini, Carolina Marotta, Giannino Del Sal · 2013 · Pharmacological Research
92. Utilization of Genomic Signatures to Identify Phenotype-Specific Drugs
    Seiichi Mori, Jeffrey T. Chang, Eran R. Andrechek, Anil Potti, Joseph R. Nevins · 2009 · PLoS ONE
93. CCK2receptor expression transforms non‐tumorigenic human NCM356 colonic epithelial cells into tumor forming cells
    Celia Chao, Xueliang Han, Kirk L. Ives, Jeseong Park, Andrey A. Kolokoltsov, Robert A. Davey, Mary Pat Moyer, Mark R. Hellmich · 2009 · International Journal of Cancer
94. Emerging RAS-directed therapies for cancer
    Michael R. Conroy, Darren Cowzer, Walter Kölch, Austin G. Duffy · 2021 · Cancer Drug Resistance
95. Phase II Study of Docetaxel and Trametinib in Patients with KRAS Mutation Positive Recurrent Non–Small Cell Lung Cancer (NSCLC; SWOG S1507, NCT-02642042)
    Shirish M. Gadgeel, Jieling Miao, Jonathan Wesley Riess, James Moon, Philip C. Mack, Gregory James Gerstner, Timothy Francis Burns, Asma Taj, Wallace Akerley, Konstantin H. Dragnev et al. · 2023 · Clinical Cancer Research
96. Genetic, Structural, and Molecular Insights into the Function of Ras of Complex Proteins Domains
    Laura Civiero, Sybille Dihanich, Patrick Alfryn Lewis, Elisa Greggio · 2014 · Chemistry & Biology
97. The Ras Antagonist, Farnesylthiosalicylic Acid (FTS), Decreases Fibrosis and Improves Muscle Strength in dy2J/dy2J Mouse Model of Muscular Dystrophy
    Yoram Nevo, Shlomit Aga‐Mizrachi, Edva Elmakayes, Nurit Yanay, Keren Ettinger, Moran Elbaz, Zivia Brunschwig, Oshrat Dadush, Galit Elad‐Sfadia, Roni Haklai et al. · 2011 · PLoS ONE
98. Rotational and Translational Dynamics of Ras Proteins upon Binding to Model Membrane Systems
    Alexander Werkmüller, Gemma Triola, Herbert Waldmann, Roland Winter · 2013 · ChemPhysChem
99. Proto-oncogenic H-Ras, K-Ras, and N-Ras are involved in muscle differentiation via phosphatidylinositol 3-kinase
    Jisun Lee, Kyu Jin Choi, Min Jin Lim, Feng Hong, Tae Gyu Choi, Eunyoung Tak, Seonmin Lee, Young-Joo Kim, Sung Goo Chang, Jin Man Cho et al. · 2010 · Cell Research
100. DNA hypermethylation biomarkers to predict response to cisplatin treatment, radiotherapy or chemoradiation: the present state of art
     Frank Roossink, Steven de Jong, G. Bea A. Wisman, Ate G.J. van der Zee, Ed M. D. Schuuring · 2012 · Cellular Oncology